We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Kensey Nash Corp. (MM) | NASDAQ:KNSY | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 0 | - |
From Jul 2019 to Jul 2024
EXTON, Pa., March 12, 2012 /PRNewswire/ -- Kensey Nash Corporation (Nasdaq: KNSY) is scheduled to present at the Sidoti & Company Sixteenth Annual New York Institutional Investor Forum on Monday, March 19, 2012 at The Grand Hyatt Hotel in New York.
Joseph W. Kaufmann, Kensey Nash's Chief Executive Officer, will deliver the Company's presentation, beginning approximately at 10:40 a.m. (ET). The presentation materials will be available on the company's website (www.kenseynash.com) beginning at 10:40 a.m. (ET) on Monday, March 19, 2012.
About Kensey Nash Corporation. Kensey Nash Corporation is a medical device company primarily focused on regenerative medicine utilizing its proprietary collagen and synthetic polymer technology. The Company is recognized as a leader for innovative product development and unique technology in the field of resorbable biomaterials. The Company has an extensive range of products, which are sold through strategic partners in multiple medical markets, including the cardiology, orthopaedic, sports medicine, spine, endovascular and general surgery markets.
SOURCE Kensey Nash Corporation
Copyright 2012 PR Newswire
1 Year Kensey Nash Chart |
1 Month Kensey Nash Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
